Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
dc.contributor.author | Kuemmerle, A. | |
dc.contributor.author | Olsson, S. | |
dc.contributor.author | Van Erps, J. | |
dc.contributor.author | Burri, C. | |
dc.contributor.author | Lalvani, P.S. | |
dc.date.accessioned | 2012-12-28T14:13:06Z | |
dc.date.accessioned | 2017-10-19T12:54:51Z | |
dc.date.available | 2012-12-28T14:13:06Z | |
dc.date.available | 2017-10-19T12:54:51Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Malaria Journal 2011, 10:57doi:10.1186/1475-2875-10-57 | en_US |
dc.identifier.uri | http://197.255.68.203/handle/123456789/1979 | |
dc.language.iso | en | en_US |
dc.publisher | Malaria Journal 2011 | en_US |
dc.title | Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring | en_US |
dc.type | Article | en_US |